Mobile Carbapenemase Genes in Pseudomonas aeruginosa

EJ Yoon, SH Jeong - Frontiers in microbiology, 2021 - frontiersin.org
Carbapenem-resistant Pseudomonas aeruginosa is one of the major concerns in clinical
settings impelling a great challenge to antimicrobial therapy for patients with infections …

Metallo-β-lactamases: a last frontier for β-lactams?

G Cornaglia, H Giamarellou… - The Lancet infectious …, 2011 - thelancet.com
Metallo-β-lactamases are resistance determinants of increasing clinical relevance in Gram-
negative bacteria. Because of their broad range, potent carbapenemase activity and …

Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit

K Razazi, LPG Derde, M Verachten, P Legrand… - Intensive care …, 2012 - Springer
Purpose The changed epidemiology of extended spectrum beta-lactamases (ESBL), the
spread to the community and the need for prudent use of carbapenems require updated …

Complete genome sequence of hypervirulent and outbreak-associated Acinetobacter baumannii strain LAC-4: epidemiology, resistance genetic determinants and …

HY Ou, SN Kuang, X He, BM Molgora, PJ Ewing… - Scientific reports, 2015 - nature.com
Acinetobacter baumannii is an important human pathogen due to its multi-drug resistance. In
this study, the genome of an ST10 outbreak A. baumannii isolate LAC-4 was completely …

Colonization and infection with extended spectrum beta-lactamase producing Enterobacteriaceae in high-risk patients–Review of the literature from a clinical …

LM Biehl, M Schmidt-Hieber, B Liss… - Critical reviews in …, 2016 - Taylor & Francis
Background: The prevalence of extended-spectrum β-lactamase producing
Enterobacteriaceae (ESBL-E) is increasing worldwide. ESBL-E are known to colonize …

Vaccine development to control the rising scourge of antibiotic-resistant Acinetobacter baumannii: a systematic review

R Singh, N Capalash, P Sharma - 3 Biotech, 2022 - Springer
Acinetobacter baumannii has emerged as one of major nosocomial pathogen and global
emergence of multidrug-resistant strains has become a challenge for developing effective …

Risk factors for Pseudomonas aeruginosa acquisition in intensive care units: a prospective multicentre study

AG Venier, C Leroyer, C Slekovec, D Talon… - Journal of Hospital …, 2014 - Elsevier
Background Pseudomonas aeruginosa is a major nosocomial pathogen in intensive care
units (ICUs); however, endogenous versus exogenous origin of contamination remains …

Immunosuppression broadens evolutionary pathways to drug resistance and treatment failure during Acinetobacter baumannii pneumonia in mice

W Huo, LM Busch, J Hernandez-Bird, E Hamami… - Nature …, 2022 - nature.com
Acinetobacter baumannii is increasingly refractory to antibiotic treatment in healthcare
settings. As is true of most human pathogens, the genetic path to antimicrobial resistance …

Emergence of tigecycline & colistin resistant Acinetobacter baumanii in patients with complicated urinary tract infections in north India

N Taneja, G Singh, M Singh… - Indian Journal of Medical …, 2011 - journals.lww.com
complicated urinary tract infection (uTI) attending the Postgraduate Institute of Medical
Education and Research, Chandigarh, India, were included. Only first isolate from the …

[HTML][HTML] Rates of fecal transmission of extended-spectrum β-lactamase-producing and carbapenem-resistant Enterobacteriaceae among patients in intensive care …

J Kim, JY Lee, SI Kim, W Song, JS Kim… - Annals of laboratory …, 2014 - ncbi.nlm.nih.gov
Background We investigated the rates of fecal transmission of extended-spectrum β-
lactamase (ESBL)-producing Enterobacteriaceae (ESBL-E) and carbapenem-resistant …